Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 6/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.48 |
| ▸ | MAPT | P10636 | 6/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | RECQL | P46063 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MPI | P34949 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29472028 | 1.00 | CYP2C9 (0.59) | CYP2C9LMNAHPGDALDH1A1MAPT | |
| SCHEMBL239325 | 1.00 | CYP2C9 (0.59) | CYP2C9LMNAHPGDALDH1A1MAPT | |
| SCHEMBL16234584 | 0.93 | CYP2C9 (0.53) | CYP2C9LMNAHPGDALDH1A1MAPT | |
| SCHEMBL17591502 | 0.89 | LMNA (0.50) | CYP2C9LMNAHPGDALDH1A1MAPT | |
| SCHEMBL14404845 | 0.89 | LMNA (0.50) | CYP2C9LMNAHPGDALDH1A1MAPT | |
| SCHEMBL12332461 | 0.86 | CYP2C9 (0.52) | CYP2C9LMNAHPGDALDH1A1MAPT | |
| SCHEMBL7091919 | 0.86 | CYP2C9 (0.52) | CYP2C9LMNAHPGDALDH1A1MAPT | |
| SCHEMBL21728463 | 0.86 | CYP2C9 (0.52) | CYP2C9LMNAHPGDALDH1A1MAPT | |
| SCHEMBL19625972 | 0.84 | LMNA (0.50) | CYP2C9LMNAHPGDALDH1A1MAPT | |
| SCHEMBL12459466 | 0.82 | CYP2C9 (0.57) | CYP2C9LMNAHPGDALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1363923-B1 | RHODIUM AND IRIDIUM COMPLEXES | MERCK PATENT GMBH (DE) | 2009-04-01 | — | — | EP | claimed |
| EP-1562964-B1 | PALLADIUM AND PLATINUM COMPLEXES | MERCK PATENT GMBH (DE) | 2006-07-19 | — | — | EP | claimed |
| US-20040138455-A1 | Rhodium and iridium complexes | MERCK PATENT GMBH (DE) | 2004-07-15 | — | — | US | claimed |
| US-12635401-B2 | Metal complexes | UDC Ireland (IE) | 2026-05-19 | — | — | US | disclosed |
| EP-4069709-B1 | METAL COMPLEXES | UDC IRELAND LTD (IE) | 2025-04-23 | — | — | EP | disclosed |
| US-12250871-B2 | Metal complexes | UDC IRELAND LIMITED (IE) | 2025-03-11 | — | — | US | disclosed |
| US-20240260448-A1 | Metal Complexes | UDC IRELAND LIMITED (IE) | 2024-08-01 | — | — | US | disclosed |
| US-11917901-B2 | Metal complexes | UDC IRELAND LIMITED (IE) | 2024-02-27 | — | — | US | disclosed |
| US-20230056324-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2023-02-23 | — | — | US | disclosed |
| US-11404649-B2 | Electroluminescent bridged metal complexes for use in electronic devices | MERCK PATENT GMBH (DE) | 2022-08-02 | — | — | US | disclosed |
| US-20220209141-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2022-06-30 | — | — | US | disclosed |
| EP-1944309-A1 | Rhodium and iridium complexes | Merck Patent GmbH (DE) | 2008-07-16 | — | — | EP | disclosed |
| EP-1558619-B1 | RHODIUM AND IRIDIUM COMPLEXES | MERCK PATENT GMBH (DE) | 2008-03-12 | — | — | EP | disclosed |
| US-20080027220-A1 | Metal Complexes | MERCK PATENT GMBH (DE) | 2008-01-31 | — | — | US | disclosed |
| US-7125998-B2 | Rhodium and iridium complexes | MERCK PATENT GMBH (DE) | 2006-10-24 | — | — | US | disclosed |
| EP-1562964-B1 | PALLADIUM AND PLATINUM COMPLEXES | MERCK PATENT GMBH (DE) | 2006-07-19 | — | — | EP | disclosed |
| US-20060071206-A1 | Palladium and platinum complexes | UDC IRELAND LIMITED (IE) | 2006-04-06 | — | — | US | disclosed |
| US-20050253135-A1 | Rhodium and iridium complexes | MERCK PATENT GMBH (DE) | 2005-11-17 | — | — | US | disclosed |
| US-20050031900-A1 | Aromatic monomer-and conjugated polymer-metal complexes | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-02-10 | — | — | US | disclosed |
| US-20040138455-A1 | Rhodium and iridium complexes | MERCK PATENT GMBH (DE) | 2004-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12635401-B2 | Metal complexes | SCO2, SOD1, NR4A1 | CYP2C9 1408/4885LMNA 556/4885HPGD 3632/4885 |
| US-20040138455-A1 | Rhodium and iridium complexes | RPIA, MPI, INPP5B | CYP2C9 817/4885LMNA 4528/4885HPGD 1683/4885 |
| US-20050253135-A1 | Rhodium and iridium complexes | RPIA, SIRT5, RAB35 | CYP2C9 1431/4885LMNA 4849/4885HPGD 1910/4885 |
| US-12250871-B2 | Metal complexes | AP1M1, SOD1, AP3M1 | CYP2C9 2421/4885LMNA 4288/4885HPGD 3841/4885 |
| US-20230056324-A1 | METAL COMPLEXES | MCU, IMMT, SOD1 | CYP2C9 2879/4885LMNA 4719/4885HPGD 3581/4885 |
| US-11404649-B2 | Electroluminescent bridged metal complexes for use in electronic devices | MCOLN2, MCOLN1, NCLN | CYP2C9 2417/4885LMNA 1174/4885HPGD 1859/4885 |
| US-20080027220-A1 | Metal Complexes | AP1M1, SOD1, AP1G1 | CYP2C9 1200/4885LMNA 4651/4885HPGD 3157/4885 |
| US-20220209141-A1 | METAL COMPLEXES | AP1M1, SOD1, AP3M1 | CYP2C9 2421/4885LMNA 4288/4885HPGD 3841/4885 |
| US-20060071206-A1 | Palladium and platinum complexes | PMS2, PDCD1, PDCD1LG2 | CYP2C9 2381/4885LMNA 4853/4885HPGD 2215/4885 |
| US-11917901-B2 | Metal complexes | MCOLN2, MCOLN1, AP1M1 | CYP2C9 3053/4885LMNA 547/4885HPGD 3283/4885 |
| US-20240260448-A1 | Metal Complexes | SOD1, AP1M1, AP3M1 | CYP2C9 2236/4885LMNA 4436/4885HPGD 3882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.